wherein R1 is selected from a group consisting of -CH2CH2CH2C(CH3)2-, -CHCHCHC(CH3)-, -CH2CH2CHC(CH3)-, or -CH2CH2CH2C(CH2)-, R2 is H or C1-C3 alkyl etc. or a pharmaceutical composition containing the same for manufacturing medicine in preventing or treatment of hyperammonemia caused by chronic hepatitis and hepatocirrhosis, including hepatic encephalopathy and subclinical hepatic encephalopathy caused by hyperammonemia etc."/>
公开/公告号EP1352653A1
专利类型
公开/公告日2003-10-15
原文格式PDF
申请/专利号EP20010940097
申请日2001-05-24
分类号A61K31/343;A61P43/00;
国家 EP
入库时间 2022-08-21 23:48:49